Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ramona Cindea-Drimus

Neuroendocrine Tumor Recurrence: Diagnosis With68Ga-Dotatate PET/CT

Radiology

English

Related publications

A Comparison of 68Ga-Dotatate and 18f-FDG PET/CT in Pulmonary Neuroendocrine Tumors

Journal of Nuclear Medicine

English

Efficacy and Limitations of 68-Gallium DOTATATE PET/CT for Neuroendocrine Tumors: Clinical Experience Following FDA Approval

English

Diagnosis of Men-I Syndrome on 68Ga-Dotanoc PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate

International Journal of Endocrinology and Metabolism

English

68Ga-Dotatate PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients With Well-Differentiated Neuroendocrine Tumors

Journal of Nuclear Medicine

English

Localization of Unknown Primary Site With 68 Ga-Dotatoc PET/CT in Patients With Metastatic Neuroendocrine Tumor

Journal of Nuclear Medicine

English

Recurrent Ovarian Cancer: Use of Contrast-Enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival

English

Epididymal Cystadenomas in Von Hippel-Lindau Disease Showing Increased Activity on 68Ga DOTATATE PET/CT

Clinical Nuclear Medicine

English

A Systematic Review of Positron Emission Tomography (PET) and Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Breast Cancer Recurrence

Health Technology Assessment

Medicine

Health Policy

2010

English

Association Between Neuroendocrine Tumors Biomarkers and Primary Tumor Site and Disease Type Based on Total68Ga-Dotatate-Avid Tumor Volume Measurements

European Journal of Endocrinology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ramona Cindea-Drimus

Neuroendocrine Tumor Recurrence: Diagnosis With68Ga-Dotatate PET/CT

Related publications

A Comparison of 68Ga-Dotatate and 18f-FDG PET/CT in Pulmonary Neuroendocrine Tumors

Efficacy and Limitations of 68-Gallium DOTATATE PET/CT for Neuroendocrine Tumors: Clinical Experience Following FDA Approval

Diagnosis of Men-I Syndrome on 68Ga-Dotanoc PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate

68Ga-Dotatate PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients With Well-Differentiated Neuroendocrine Tumors

Localization of Unknown Primary Site With 68 Ga-Dotatoc PET/CT in Patients With Metastatic Neuroendocrine Tumor

Recurrent Ovarian Cancer: Use of Contrast-Enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival

Epididymal Cystadenomas in Von Hippel-Lindau Disease Showing Increased Activity on 68Ga DOTATATE PET/CT

A Systematic Review of Positron Emission Tomography (PET) and Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Breast Cancer Recurrence

Association Between Neuroendocrine Tumors Biomarkers and Primary Tumor Site and Disease Type Based on Total68Ga-Dotatate-Avid Tumor Volume Measurements